PAPILLOMAVIRUS INFECTION AND CERVICAL CANCER INCIDENCE IN PRE-VACCINATION AND THE INITIAL VACCINATION PERIODS IN THE REPUBLIC OF SAKHA (YAKUTIA)

被引:0
|
作者
Ignatieva, M. E.
Lyalina, L., V
Smetanina, V. D.
Karpova, I. I.
Afanasieva, L. N.
机构
来源
YAKUT MEDICAL JOURNAL | 2012年 / 03期
关键词
human papillomavirus infection; cervical cancer; morbidity; prevalence; vaccination;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The research aims at studying patterns and regional characteristics of morbidity and incidence of various papillomavirus infection and cervical cancer forms in the Republic of Sakha (Yakutia) in the pre-vaccination period and the first years of vaccination against this pathology. It is established that the studied periods do not show any significant differences or decreasing trend in anogenital (venereal) warts morbidity. The study revealed higher (by 1/6-2 times) incidence of high-risk HPV of type 16 in women, compared with men. There was no decrease in type 16 and 18 HPV incidence in 2008-2011 (the period of introducing low vaccination coverage), compared with the year 2007. There is a trend for increased CC morbidity in women aged 30-44 years.
引用
收藏
页码:118 / 125
页数:8
相关论文
共 50 条
  • [41] Cervical cancer screening following prophylactic human papillomavirus vaccination
    Franco, Eduardo L.
    Cuzick, Jack
    VACCINE, 2008, 26 : A16 - A23
  • [42] Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe
    Chin'ombe, Nyasha
    Sebata, Natasha L.
    Ruhanya, Vurayai
    Matarira, Hilda T.
    INFECTIOUS AGENTS AND CANCER, 2014, 9
  • [43] Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives
    Chan, Chee Kai
    Aimagambetova, Gulzhanat
    Ukybassova, Talshyn
    Kongrtay, Kuralay
    Azizan, Azliyati
    JOURNAL OF ONCOLOGY, 2019, 2019
  • [44] The impact of human papillomavirus vaccination on cervical cancer prevention efforts
    Massad, L. Stewart
    Einstein, Mark
    Myers, Evan
    Wheeler, Cosette M.
    Wentzensen, Nicolas
    Solomon, Diane
    GYNECOLOGIC ONCOLOGY, 2009, 114 (02) : 360 - 364
  • [45] Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination
    Budd, Alison C.
    Sturrock, Christine J.
    SEXUAL HEALTH, 2010, 7 (03) : 328 - 334
  • [46] Moving forward: Human papillomavirus vaccination and the prevention of cervical cancer
    Vetter, Kathleen M.
    Geller, Stacie E.
    JOURNAL OF WOMENS HEALTH, 2007, 16 (09) : 1258 - 1268
  • [47] Effect of human papillomavirus vaccination on cervical cancer screening in Alberta
    Kim, Jong
    Bell, Christopher
    Sun, Maggie
    Kliewer, Gordon
    Xu, Linan
    McInerney, Maria
    Svenson, Lawrence W.
    Yang, Huiming
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (12) : E281 - E288
  • [48] Clarification on the impact of cervarix vaccination on human papillomavirus infection and cervical cancer in the United Kingdom Response
    Taylor, Sylvia
    Ryser, Martin
    Mihalyi, Attila
    van Effelterre, Thierry
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (07) : 1943 - 1946
  • [49] Projected impact of Cervarix™ vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom
    Van Effelterre, Thierry P.
    Hogea, Cosmina
    Taylor, Sylvia M.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (01) : 8 - 19
  • [50] Pre-vaccination Prevalence and Genotype Distribution of Human Papillomavirus Infection among Women from Urban Tunis: a Cross-sectional Study
    Guettiti, Haifa
    Ennaifer, Emna
    Attia, Leila
    Chelly, Dalenda
    Ben Alaya, Nissaf
    Ben Aissa, Rim
    Laassili, Thalja
    Boubaker, Samir
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (21) : 9361 - 9365